AngioDynamics, Inc.
AngioDynamics, Inc., a leading medical device company headquartered in the United States, has been at the forefront of innovative solutions since its founding in 1988. Specialising in the development of products for vascular access, oncology, and surgical procedures, AngioDynamics is renowned for its commitment to improving patient outcomes through advanced technology. With a strong presence in North America and expanding operations in international markets, the company offers a diverse range of core products, including catheter systems, ablation devices, and imaging solutions. AngioDynamics distinguishes itself through its focus on minimally invasive techniques, which enhance safety and efficacy in various medical applications. Recognised for its significant contributions to the healthcare industry, AngioDynamics continues to solidify its market position with a dedication to innovation and quality, making it a trusted name among healthcare professionals worldwide.
DitchCarbon Score
How does AngioDynamics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
AngioDynamics, Inc.'s score of 25 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
AngioDynamics, Inc.'s reported carbon emissions
AngioDynamics, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company has not disclosed any climate commitments or pledges, indicating a lack of formalised strategies towards emissions reduction or sustainability efforts at this time. As such, there are no specific figures or scopes of emissions (Scope 1, 2, or 3) to report. In the absence of concrete data, it is essential to note that many organisations in the medical device industry are increasingly focusing on sustainability and climate action. However, AngioDynamics, Inc. has yet to publicly align with such initiatives or disclose any related commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
AngioDynamics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
